anmelden
FTSE All-Share
5.735,46
PKT
+15,93
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.09.20 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 14.09.20 | Rio Tinto Neutral | UBS AG | |
| 14.09.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 14.09.20 | BP Outperform | Credit Suisse Group | |
| 11.09.20 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 11.09.20 | Rio Tinto buy | Jefferies & Company Inc. | |
| 11.09.20 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 11.09.20 | BP overweight | Barclays Capital | |
| 11.09.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 10.09.20 | Rio Tinto Underperform | Credit Suisse Group | |
| 10.09.20 | BP buy | UBS AG | |
| 10.09.20 | London Stock Exchange (LSE) overweight | JP Morgan Chase & Co. | |
| 10.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 09.09.20 | BP buy | Kepler Cheuvreux | |
| 09.09.20 | AstraZeneca Sell | UBS AG | |
| 09.09.20 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 09.09.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.09.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.09.20 | AstraZeneca overweight | Barclays Capital | |
| 08.09.20 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 08.09.20 | Prudential overweight | Barclays Capital | |
| 08.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.09.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.09.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 04.09.20 | Barclays buy | UBS AG | |
| 04.09.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 04.09.20 | Unilever Sell | UBS AG | |
| 04.09.20 | Unilever Sell | UBS AG | |
| 04.09.20 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 04.09.20 | HSBC Underperform | RBC Capital Markets | |
| 04.09.20 | Barclays Sector Perform | RBC Capital Markets | |
| 04.09.20 | Imperial Brands overweight | JP Morgan Chase & Co. | |
| 03.09.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 03.09.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.09.20 | National Grid buy | UBS AG | |
| 03.09.20 | London Stock Exchange (LSE) overweight | JP Morgan Chase & Co. | |
| 01.09.20 | GSK verkaufen | Morgan Stanley | |
| 01.09.20 | BP overweight | JP Morgan Chase & Co. | |
| 01.09.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. |